May 21, 2024

Enteral Feeding Formulas Market Size to Reach USD 12.51 Bn by 2033

The global enteral feeding formulas market size was estimated at USD 7.26 billion in 2023 and is predicted to reach around USD 12.51 billion by 2033, growing at a CAGR of 5.59% from 2024 to 2033.

Key Points

  • The North America enteral feeding formulas market size was estimated at USD 2.32 billion in 2023 and is expected to surpass around USD 4 billion by 2033.
  • North America held the largest market share of 32% in 2023.
  • By product, the standard formula segment dominated the market with the largest market share of 58% in 2023.
  • By flow type, intermittent feeding flow segment has captured the largest market share of 90% in 2023.
  • By stage, the adult segment has accounted for the largest share of 91% in 2023.
  • By indication, the cancer care segment held a significant share of the market in 2023.
  • By sales channel, the institutional segments dominated the market with the highest market share of 52% in 2023.
  • By end use, the home care segment is expected to grow at the fastest CAGR of 5.92% over the forecast period.

Enteral Feeding Formulas Market Size 2024 to 2033

The enteral feeding formulas market encompasses a range of specialized nutritional products designed for individuals who are unable to consume food orally. These formulas provide essential nutrients directly into the digestive tract through a feeding tube. The market for enteral feeding formulas has witnessed steady growth due to the rising prevalence of chronic diseases, advancements in medical technology, and an aging population worldwide.

Get a Sample:

Growth Factors

Several factors contribute to the growth of the enteral feeding formulas market. Increasing incidences of chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions drive the demand for enteral nutrition. Additionally, advancements in formula compositions, including specialized formulas for specific medical conditions, have expanded the market. Moreover, the growing awareness among healthcare professionals and patients regarding the benefits of enteral feeding has further propelled market growth.

Region Insights:

The enteral feeding formulas market exhibits variations across different regions globally. Developed regions such as North America and Europe dominate the market due to well-established healthcare infrastructure, higher healthcare spending, and greater awareness about enteral nutrition. In contrast, developing regions in Asia-Pacific and Latin America are witnessing rapid market expansion attributed to improving healthcare facilities, increasing disposable income, and a rising prevalence of chronic diseases.

Enteral Feeding Formulas Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 5.59%
Global Market Size in 2023 USD 7.26 Billion
Global Market Size in 2024 USD 7.67 Billion
Global Market Size by 2033 USD 12.51 Billion
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product, By Flow Type, By Stage, By Indication, By End-use, and By Sales Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Enteral Feeding Formulas Market Dynamics


The market for enteral feeding formulas is diverse, catering to various patient populations and medical conditions. Diversification in product offerings includes standard polymeric formulas for general nutritional support, disease-specific formulas tailored to manage specific medical conditions, and specialized formulas for pediatric, geriatric, and critically ill patients. Furthermore, manufacturers are innovating by introducing organic, gluten-free, and plant-based formulas to cater to diverse dietary preferences and health-conscious consumers.


The enteral feeding formulas market presents several opportunities for growth and innovation. Expansion into emerging markets, such as Asia-Pacific and Latin America, offers significant growth potential due to increasing healthcare investments and a rising geriatric population. Moreover, partnerships and collaborations between healthcare providers, manufacturers, and research institutions can foster innovation in formula development, improving patient outcomes and expanding market reach.


Despite the growth prospects, the enteral feeding formulas market faces certain challenges. Regulatory hurdles and stringent approval processes for new formulations can hinder market entry and innovation. Additionally, reimbursement policies and insurance coverage for enteral nutrition may vary between regions, affecting patient access to these products. Furthermore, concerns regarding the safety and efficacy of enteral feeding, as well as potential complications such as tube-related infections, pose challenges to market growth.

Read Also: Dental Compressors Market Size to Worth USD 620.95 Mn by 2033

Enteral Feeding Formulas Market Recent Developments

  • In September 2023, Abbott announced the plan to boost the manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.
  • In February 2023, Nestlé and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake.
  • In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.
  • In September 2022, Kate Farms raised $75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.

Enteral Feeding Formulas Market Companies

  • Nestlé S.A.
  • Abbott Laboratories
  • Mead Johnson Nutrition Company
  • Fresenius Kabi AG
  • Danone S.A.
  • Victus Inc.
  • Hormel Foods, LLC
  • B. Braun Melsungen AG
  • Global Health Product Inc.
  • Aveanna Healthcare
  • Meiji Holdings Co., Ltd.
  • Nutricia

Segments Covered in the Report

By Product

  • Standard Formula
  • Disease-specific Formulas
    • Alzheimer’s
    • Nutrition Deficiency
    • Cancer Care
    • Diabetes
    • Chronic Kidney Diseases
    • Orphan Diseases
    •  Dysphagia
    •  Pain Management
    • Malabsorption/GI Disorder/Diarrhea
    • Others

By Flow Type

  • Intermittent Feeding Flow
  • Continuous Feeding Flow

By Stage

  • Adults
  • Pediatrics

By Indication

  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By End-use

  • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
  • Home Care
  • Long-Term Care Facilities

By Sales Channel

  • Online Sales
  • Retail Sales
  • Institutional Sales

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333








I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *